Stocks · Health care · Surgical & Medical Instruments & Apparatus

CVRx, Inc.

CVRX Clue Score61
United States Fiscal year ends December CIK 0001235912 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paul Verrastro
19 Nov 2024
Chief Mktg & Strat Officer
Sold after exercise
1,430
$13.58
$19.42K
Paul Verrastro
20 Feb 2024
Chief Mktg & Strat Officer
Sold after exercise
2,545
$21.91
$55.75K
& Johnson Johnson
16 Feb 2024
10% owner
Sold after exercise indirect
3,725
$25.81
$96.14K
Paul Verrastro
31 Jul 2023
Chief Mktg & Strat Officer
Sold after exercise
1,122
$17.49
$19.63K
Paul Verrastro
28 Nov 2022
Chief Mktg & Strat Officer
Sold after exercise
600
$12.52
$7.51K
Paul Verrastro
28 Nov 2022
Chief Mktg & Strat Officer
Sold after exercise
4,000
$11.85
$47.42K

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 6
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 16,679,432
History held since 1 Jul 2021